Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q2 FY25 Earnings Presentation
38 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Nov 7, 2024
Slide 1: Cover letter to stock exchanges
November 7, 2024 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 54
Slide 2: Q2 & H1 FY25 Earnings Presentation
Q2 & H1 FY25 Earnings Presentation Nov 7, 2024
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t
Slide 4: Q2 & H1 FY25 Performance Highlights
Q2 & H1 FY25 Performance Highlights
Slide 5: H1 FY25 Performance Summary
H1 FY25 Performance Summary Bed Capacity* Revenue EBITDA EBITDA Margin 2,300+ beds Rs. 4,296 mn Rs. 1,083 mn 25.2% +32% YoY +25% YoY -149bps YoY PAT PAT Margin ROCE ROE Rs. 613 mn 14.3% 23% 14% +32% YoY -4bps YoY Working Capital Occupancy ARPOB ALOS 104 days 61% Rs. 30,597 4.42 +7% YoY +10% YoY *1,6
Slide 6: Q2 FY25 Performance Summary
Q2 FY25 Performance Summary Revenue EBITDA EBITDA Margin Rs. 2,178 mn Rs. 546 mn 25.1% +27% YoY +20% YoY -152bps YoY PAT PAT Margin Net Cash Rs. 310 mn 14.2% -190bps YoY Rs. 1,541 mn +12% YoY Occupancy ARPOB ALOS 60% Rs. 30,641 4.30 +3% YoY +11% YoY 5
Slide 7: Robust Improvement in Financial Parameters
Robust Improvement in Financial Parameters Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 80 0 30% 795 790 27.8% 785 780 +27% YoY 775 29% 770 765 760 26.6% 755 750 745 28% 26.2% 740 735 730 725 25.3% 720 27% 715 25.1% 710 705 700 69 5 26% 69 0 +3% QoQ 68 5 68 0 675 670 66 5 25% 66 0 65 5 65 0 64 5 64 0 24
Slide 8: Healthy performances across operational metrics
Healthy performances across operational metrics IPD & OPD Volumes (in ‘000s) Occupancy (%) 61% 60% IPD Volume OPD Volume 116 57% 57% 98 94 102 90 52% 99 86 82 78 87 13 12 12 15 17 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q2FY25 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q2FY25 IPD & OPD Revenue (Rs mn) ARPOB (Rs.) IPD Revenue
Slide 9: Diversifying revenues across hospitals
Diversifying revenues across hospitals Greater Greater Noida Noida 36% Faridabad 31% Jhansi- 4% Orchha 5% Jhansi- Orchha Q2 FY24 7% Q2 FY25 Noida Noida Extension Noida Extension 37% 28% 31% Noida 21% Noida extension registers solid growth at 53% YoY, contributing 37% to Group’s revenue 8
Slide 10: Expanding high value specialties across hospitals
Expanding high value specialties across hospitals Diverse mix of specialties at all hospitals Noida extension hospital registered highest share of super specialties Q2 19% 12% 11% 10% 10% 8% 6% 6% 5% 4% 4% FY2025 Pediatrics 3% Oncology Pulmonology 19% 5% Gynecology Q2 5% 33% 10% 3% 9% 9% 7% FY2024 G
Slide 11: Operational Highlights for the quarter
Operational Highlights for the quarter Capacity Expansion, through strategic acquisitions • Successful bid for super specialty hospital in Delhi, with an expandable capacity of 300+ beds Improvement in occupancy across our hospitals • Strategic collaboration to acquire ~60% stake in a • Occupancy le
Slide 12: Expanding footprints in New Delhi market, with ~300 beds
Expanding footprints in New Delhi market, with ~300 beds Well established Multi-specialty hospital Established in 2019 Expandable to 300+ Beds ❖ Successful bid for MD City Hospital in Delhi through the e-auction process under the Acquisition Cost ~Rs. 160 crore SARFAESI Act, 2002 ❖ The hospital is w
Slide 13: Acquiring majority stake in 400-bedded Faridabad hospital
Acquiring majority stake in 400-bedded Faridabad hospital Yet to commence Multi-specialty hospital Built on approx. 2 Acre land Proposed Capacity 400 Beds ❖ Strategic collaboration agreement for ~60% stake acquisition in ~400 bed-hospital in Faridabad Majority stake being acquired Rs. 91 crore ❖ Hos
Slide 14: Business highlights during the period
Business highlights during the period Clinical Achievements Other highlights ➢ Yatharth Hospitals has been ranked amongst top 2 hospitals in Top Hospitals & Clinics in India survey of 2024, for Ghaziabad, Noida & Gr. Noida region. ➢ Company has received Credit Rating of CRISIL A- with Stable Outlook
Slide 15: Profit & Loss Summary
Profit & Loss Summary Change Change Change Particulars (Rs Mn) Q2FY25 Q2FY24 Q1FY25 H1FY25 H1FY24 YoY QoQ YoY Revenue from Operations 2,178 1,713 27% 2,118 3% 4,296 3,258 32% Medical Consumables & Pharmacy 432 360 20% 468 (8%) 900 641 40% Employee Expenses 415 284 46% 346 20% 761 552 38% Other Expen
Slide 16: Balance Sheet
Balance Sheet Particulars (Rs Mn) Sep-24 Mar-24 Particulars (Rs Mn) Sep-24 Mar-24 Shareholders Equity 9,323 8,743 Fixed Assets (incl. Goodwill) 5,090 4,405 Borrowings 896 831 Right to Use Assets 4 14 Lease Liabilities 5 16 Financial Assets 128 243 Trade Payables 289 292 Inventories 143 81 Other fina
Slide 17: At a Glance
At a Glance
Slide 18: Leading super specialty hospital in North India
Leading super specialty hospital in North India Among top 10 largest private hospitals of Delhi NCR region in terms of number of beds One-stop destination for patient needs providing all levels of 7 10 87% healthcare services from primary to tertiary Hospitals* Center of Excellence Beds in Metros* 2
Slide 19: Empowering Health, Enriching Lives
Empowering Health, Enriching Lives Our unwavering commitment to patient-centric care is supported by three strategic pillars To evolve as the most preferred destination for quality healthcare that provides a comprehensive range of services and is trusted for personalized care with compassion Clinici
Slide 20: Our Journey
Our Journey Growing presence across regions and services Established our first Expansion of our first Acquisition of 4th hospital - Acquired 5th hospital – hospital in Greater hospital, Greater Noida Jhansi Orchha hospital 200 beds in Gr. Faridabad; Noida hospital, to 400 beds adding 305 beds, pursu
Slide 21: Our Hospitals
Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure Greater Noida Jhansi - Greater Diversified revenue mix Hospitals Noida Noida Extension Orchha Faridabad across hospitals Year of Operation 2010 2013 2019 2022 2024 Beds Capacity 400 250 450 305 200 Faridabad 4
Slide 22: Our Mature Hospitals
Our Mature Hospitals 65% Occupancy Provides a wide spectrum of super specialty services in the field of Greater Noida cardiology, cardiovascular and thoracic surgery, neurology, 2010 Incorporated 33,827ARPOB neurosurgery, urology, nephrology, oncology, gastroenterology etc. 400 Beds; 112 ICU Beds St
Slide 23: Our New hospitals
Our New hospitals 48% Jhansi – Occupancy One of the largest hospital in Jhansi-Orchha-Gwalior region, has infrastructure to operate all the major super Orchha 13,854 specialties ARPOB 2022 Acquisition Acquired in FY22, aimed at further expanding into new 305 Beds; 76 ICU Beds geographies and growing
Slide 24: Delhi NCR market is poised for substantial expansion
Delhi NCR market is poised for substantial expansion Delhi NCR bed density is lower compared to other metros Patient influx from neighboring regions with lower density 43 40 36 33 30 27 23 22 21 13 12 11 11 8 MMR HP Rajasthan Haryana MP Bengaluru Delhi-NCR Hyderabad Pune Chennai Uttarakhand UP Ghazi
Slide 25: Proximity to international airports to fuel medical tourism
Proximity to international airports to fuel medical tourism India’s medical tourism industry has been growing ~45% of the international patients travel to Delhi-NCR 40% Indira Gandhi Int. Airport Noida Extension (~42 km from IGI; 7.0 Model Town, Delhi 58 km from Jewar) 6.4 (~24 km from IGI) Noida 5.
Slide 26: Yatharth is well positioned in most of the levers
Yatharth is well positioned in most of the levers Yatharth Apollo Max Fortis NH KIMS Jupiter Strategic Levers to improve competence No of beds Beds in ✓ On track to expand bed Metros % capacity to ~3,000 by FY28 Revenue ✓ Increasing share of super 3Y CAGR specialties & introduction of oncology and r
Slide 27: Core strategies driving growth
Core strategies driving growth Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals 01 Capacity Addition 02 Greenfield and brownfield expansion Leverage Technology 03 Advanced and high-end medical equipment and technology 04 Clinical Expertise Attracting best talent to drive
Slide 28: Optimizing existing infrastructure
Optimizing existing infrastructure Mature hospitals New hospitals Total Occupancy (%) 67% 63% 61% 55% 54% 50% 50% Improve 42% 45% 42% Diversifying 42% customer specialties service 23% 8% NM NM FY21 FY22 FY23 FY24 H1FY25 Our 5-fold approach to optimize 34,049 existing infra 29,646 28,571 30,597 Optim
Slide 29: Capacity addition - greenfield and brownfield expansion
Capacity addition - greenfield and brownfield expansion Capacity addition trend and roadmap ahead Operational Beds New bed addition Planned bed addition Target bed capacity 450 ~3,000 ~200-300 ~400 ~300 Operationalize Operationalize by Q1 FY26 May-24 by Q1 FY26 Apr-22 May-19 • Acquired well-establis
Slide 30: Advanced and high-end medical equipment and technology
Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce cutting-edge medical technology and state-of-the-art equipment Complex Kidney, Liver & Bone Robotic Surgeries – Marrow Transplant DaVinci, Mak
Slide 31: Attracting best talent to drive super specialties
Attracting best talent to drive super specialties Strategic initiatives aimed to ease attrition Integrating talent from First mover advantage in well-established allied building out network across workforce Tier II/III cities ❑ Introduced DNB program across 8 specialties in 2 of the hospitals ❑ DNB
Slide 32: Proven record of consistent financial performance (1/2)
Proven record of consistent financial performance (1/2) Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 29.3% 2300 2295 30% 2290 2285 2280 2275 2270 2265 2260 2255 2250 27.6% 2245 2240 2235 2230 2225 2220 29% 2215 2210 2205 2200 219 219 5 0 26.8% 218 218 5 0 26.7% 2175 2170 216 216 5 0 215 215 5 0 28% 214
Slide 33: Proven record of consistent financial performance (2/2)
Proven record of consistent financial performance (2/2) Return on capital employed (%) Return on equity (%) 29% 45% 44% 28% 27% 23% 27% 22% 18% 14% FY21 FY22 FY23 FY24 H1FY25 FY21 FY22 FY23 FY24 H1FY25 Gross Block (Rs mn) 130 Net Working Capital Days 125 Capex per bed 120 115 110 105 4.40 100 95 3.9
Slide 34: Consistent performance across operational parameters
Consistent performance across operational parameters IPD/OPD Volume (in ‘000s) IPD/OPD Revenue (in ‘000s) IPD Volume OPD Volume IPD Revenue OPD Revenue 6,705 375 376 5,203 819 256 4,009 4,296 218 684 192 3,258 506 157 330 327 2,287 546 5,886 410 223 186 227 4,519 3,790 136 167 3,464 2,848 2,060 21 3
Slide 35: Strengthened balance sheet with IPO proceeds
Strengthened balance sheet with IPO proceeds Net Worth (Rs mn) 9,323 Amt. Raised Utilisation 8,743 10000 0.27 0.26 0.25 90 00 0.24 0.23 0.22 80 00 0.21 Debt Repayment 2,450 mn 99% 0.2 0.19 40% 7000 0.18 0.17 60 00 0.16 0.15 0.14 50 00 0.13 0.12 Organic Capex 1,326 mn 59% 0.11 40 00 0.1 1,830 0.09 30
Slide 36: Awards and Accreditations
Awards and Accreditations 2020 2021 2023 2024 ➢ Awarded 1st in Swachhta ➢ Covid Thank You award by Niva ➢ Awarded UP Ratan Samman by ➢ Awarded Best Brand for Ranking (for quarter ended Bupa Dainik Jagran Inext Excellence in Healthcare at Sep 2019) in Swachh ➢ 5-star grading by Infomerics ➢ Accredita
Slide 37: Experienced board and leadership team
Experienced board and leadership team Promila Bhardwaj Dr. Ajay Kumar Tyagi Independent Director Chairman & Whole-time Director 35+ yrs of experience 17+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social Bachelor of medicine, surgery, and diploma in orthopaedics s
Slide 38: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Neeraj Vinayak, Head – Strategy and Investor Relations investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital and Trauma Care Services — Q2 FY25 Earnings Presentation on 6ix